The U.S. Food and Drug Administration’s drug approval database includes an entry for a prednisolone tablet (5 mg) submitted under application number ANDA080236. The product is listed as an oral tablet, with product number 001, and is not designated as a reference drug.
The sponsor is Valeant Pharmaceuticals International. The marketing status for this product is recorded as “Discontinued,” indicating it is no longer marketed in the United States.
規制動向2026年9月19日•3分で読めます
FDA Lists Prednisolone 5 mg Tablet (ANDA080236) from Valeant as Discontinued
The FDA database shows a prednisolone 5 mg oral tablet submitted under ANDA080236 by Valeant Pharmaceuticals International, currently marked as discontinued.
Pharmacountryチームがまとめました · 出典： FDA.gov
トピック：
評価
(0)
(0)
(0)
(0)
(0)
評価を残す